OMNICELL,INC. (NASDAQ:OMCL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On July22, 2017, at a meeting of the Compensation Committee (the “Committee”) of the Board of Directors of Omnicell,Inc. (the “Company”), the Committee approved 2017 annualized base salaries for the Company’s executive officers as set forth in the table below. The foregoing increases reflect the only base salary increases received by the Company’s executive officers for 2017, and are effective as of June 26, 2017. In addition, the Committee approved an increase in Mr. Kuipers’ annual bonus target from 70% of his base salary to 90% of his base salary, effective as of June 26, 2017.
The Committee has historically made decisions regarding executive compensation, including changes to the executive officers’ base salaries, during February, however, as previously disclosed by the Company on a Current Report on Form 8-K, at its meeting held on February 8, 2017, the Committee determined not to change the executive officers’ annualized base salaries from the salaries then in effect at that time.
|
Name |
Title |
2017 Annualized BaseSalary |
2017 Bonus Target (Percentage of BaseSalary) |
||
|
Randall A. Lipps |
Chairman, President and Chief Executive Officer |
$ |
680,000 |
% |
|
|
Peter J. Kuipers |
Executive Vice President and Chief Financial Officer |
$ |
390,000 |
% |
|
|
J. Christopher Drew |
President, North American Automation |
$ |
390,000 |
% |
|
|
Robin G. Seim |
President, Global Automation and Medication Adherence |
$ |
390,000 |
% |
|
|
Nhat Ngo |
Executive Vice President, Strategy and Business Development |
$ |
325,000 |
% |
|
|
Dan S. Johnston |
Executive Vice President and Chief Legal and Administrative Officer |
$ |
310,000 |
% |
|
|
Jorge Taborga |
Executive Vice President, Engineering |
$ |
300,000 |
% |
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit Number |
Description |
|
10.1 |
2017 Executive Officer Annual Base Salaries |
About OMNICELL,INC. (NASDAQ:OMCL)
Omnicell, Inc. (Omnicell) is a provider of automation and business information solutions designed to enable healthcare systems to streamline the medication administration process and manage medical supplies for increased operational efficiency and enhanced patient safety. The Company operates through two operating segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment organizes the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems, and related software. The Medication Adherence segment primarily includes the manufacturing and selling of consumable medication blister cards, packaging equipment and ancillary products and services. Its product line includes OmniRx, SinglePointe, AnywhereRN, Omnicell and Pandora Data Analytics, Savvy Mobile Medication System, Central Pharmacy and Satellite Pharmacy Manager, Anesthesia Workstation and Advanced Interoperability products.